After considerable anticipation, the FDA has finally eased restrictions on how the Vivus diet pill can be made accessible. By amending a Risk Evaluation & Mitigation Strategy, or REMS, Qsymia can now be sold through a network of certified retail pharmacies. The drugmaker plans to active this network in about three months.